Literature DB >> 30054801

Global HBV burden: guesstimates and facts.

Dina Ginzberg1,2, Robert J Wong3, Robert Gish1,2.   

Abstract

Chronic hepatitis B virus infection (HBV) continues to pose a serious global health threat in many areas of the world, particularly in sub-Saharan Africa, the Western Pacific Region and areas of Eastern Europe. Endemicity is heterogeneous within and across regions owing to variable implementation of childhood and birth-dose vaccination programs, inconsistent screening of blood products, injection drug use, and poor education initiatives. This review aims to provide comprehensive up-to-date estimates of global seroprevalence of chronic HBV across six World Health Organization (WHO) regions, noting patterns of change over time and highlighting potential region-specific barriers to the diagnosis and elimination of HBV.

Entities:  

Keywords:  Chronic liver disease; Global prevalence; Hepatitis B virus; Seroprevalence; Viral hepatitis

Mesh：

Year:  2018        PMID： 30054801     DOI： 10.1007/s12072-018-9884-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


  62 in total

Review 1.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

2.  Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia.

Authors:  Yusuke Shimakawa; Maud Lemoine; Harr Freeya Njai; Christian Bottomley; Gibril Ndow; Robert D Goldin; Abdoulie Jatta; Adam Jeng-Barry; Rita Wegmuller; Sophie E Moore; Ignatius Baldeh; Makie Taal; Umberto D'Alessandro; Hilton Whittle; Ramou Njie; Mark Thursz; Maimuna Mendy
Journal:  Gut       Date:  2015-07-16       Impact factor: 23.059

Review 3.  Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis.

Authors:  Charline Leroi; Pierrick Adam; Woottichai Khamduang; Suttipong Kawilapat; Nicole Ngo-Giang-Huong; Sumet Ongwandee; Suchada Jiamsiri; Gonzague Jourdain
Journal:  Int J Infect Dis       Date:  2016-08-28       Impact factor: 3.623

Review 4.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-03-27

5.  Long-term outcome in children with chronic hepatitis B: a 24-year observation period.

Authors:  Raffaele Iorio; Antonietta Giannattasio; Francesco Cirillo; Luca D' Alessandro; Angela Vegnente
Journal:  Clin Infect Dis       Date:  2007-09-07       Impact factor: 9.079

Review 6.  Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis.

Authors:  Maureen M Jonas; Anna S F Lok; Brian J McMahon; Robert S Brown; John B Wong; Ahmed T Ahmed; Wigdan Farah; Mohamed A Mouchli; Siddharth Singh; Larry J Prokop; Mohammad Hassan Murad; Khaled Mohammed
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

Review 7.  Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.

Authors:  Lana Childs; Sigrun Roesel; Rania A Tohme
Journal:  Vaccine       Date:  2017-11-22       Impact factor: 3.641

8.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.

Authors:  Jeffrey D Stanaway; Abraham D Flaxman; Mohsen Naghavi; Christina Fitzmaurice; Theo Vos; Ibrahim Abubakar; Laith J Abu-Raddad; Reza Assadi; Neeraj Bhala; Benjamin Cowie; Mohammad H Forouzanfour; Justina Groeger; Khayriyyah Mohd Hanafiah; Kathryn H Jacobsen; Spencer L James; Jennifer MacLachlan; Reza Malekzadeh; Natasha K Martin; Ali A Mokdad; Ali H Mokdad; Christopher J L Murray; Dietrich Plass; Saleem Rana; David B Rein; Jan Hendrik Richardus; Juan Sanabria; Mete Saylan; Saeid Shahraz; Samuel So; Vasiliy V Vlassov; Elisabete Weiderpass; Steven T Wiersma; Mustafa Younis; Chuanhua Yu; Maysaa El Sayed Zaki; Graham S Cooke
Journal:  Lancet       Date:  2016-07-07       Impact factor: 79.321

9.  Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.

Authors:  Erika F Duffell; Dagmar Hedrich; Otilia Mardh; Antons Mozalevskis
Journal:  Euro Surveill       Date:  2017-03-02

Review 10.  Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease.

Authors:  Noele P Nelson; Philippa J Easterbrook; Brian J McMahon
Journal:  Clin Liver Dis       Date:  2016-11       Impact factor: 6.126
View more
  13 in total

1.  Effect of Hepatocyte Targeting Nanopreparation Syringopicroside on Duck Hepatitis B Virus and Evaluation of Its Safety.

Authors:  X W Zhang; M C Li; J J Dou
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.804

2.  Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.

Authors:  Robert L Kruse; Xavier Legras; Mercedes Barzi
Journal:  Virus Res       Date:  2020-11-06       Impact factor: 3.303

3.  Survivin expression starts before hepatocellular cancer development in the liver of chronic hepatitis B patients: a pilot, cross-sectional study.

Authors:  Muhammet Yener Akpinar; Gulcin Guler Simsek; Evrim Kahramanoglu Aksoy; Ferda Pirincci Sapmaz; Selen Kantarci; Metin Uzman; Yasar Nazligul
Journal:  Prz Gastroenterol       Date:  2019-08-08

4.  A Universal Plug-and-Display Vaccine Carrier Based on HBsAg VLP to Maximize Effective Antibody Response.

Authors:  Arianna Marini; Yu Zhou; Yuanyuan Li; Iona J Taylor; Darren B Leneghan; Jing Jin; Marija Zaric; David Mekhaiel; Carole A Long; Kazutoyo Miura; Sumi Biswas
Journal:  Front Immunol       Date:  2019-12-12       Impact factor: 7.561

Review 5.  Mechanisms Mediating Nuclear Trafficking Involved in Viral Propagation by DNA Viruses.

Authors:  Guohui Li; Xinyu Qi; Zhaoyang Hu; Qi Tang
Journal:  Viruses       Date:  2019-11-07       Impact factor: 5.048

6.  Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase.

Authors:  Song Hu; Hualong Xiong; Xiaozhen Kang; Shaojuan Wang; Tianying Zhang; Quan Yuan; Deying Tian
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships.

Authors:  Wei-Cheng Huang; Yu-Chen Lin; Po-Ju Chen; Nien-Tzu Hsu; Chia-Ling Tu; Te-Sheng Chang; Chao-Hung Hung; Kwong-Ming Kee; Wen-Hua Chao; Sheng-Nan Lu
Journal:  Viruses       Date:  2022-02-01       Impact factor: 5.048

8.  Characterization of occult hepatitis B in high-risk populations in Kenya.

Authors:  Kiptoon Beatrice Jepkemei; Missiani Ochwoto; Ken Swidinsky; Jacqueline Day; Henok Gebrebrhan; Lyle R McKinnon; Anton Andonov; Julius Oyugi; Joshua Kimani; George Gachara; Elijah Maritim Songok; Carla Osiowy
Journal:  PLoS One       Date:  2020-05-28       Impact factor: 3.240

9.  Identifying potential biomarkers in hepatitis B virus infection and its response to the antiviral therapy by integrated bioinformatic analysis.

Authors:  Yi He; Yingzhi Zhou; Huimin Wang; Jingyang Yin; Yunan Chang; Peng Hu; Hong Ren; Hongmei Xu
Journal:  J Cell Mol Med       Date:  2021-05-26       Impact factor: 5.310

10.  An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: Implications for transfusion safety.

Authors:  Marion Vermeulen; Ronel Swanevelder; Gert Van Zyl; Nico Lelie; Edward L Murphy
Journal:  Transfusion       Date:  2021-06-26       Impact factor: 3.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.